| Line 775: | Line 775: | ||
='''Expansion/Contraction of the Alternative Nicotine Products Market vs Smoking'''= | ='''Expansion/Contraction of the Alternative Nicotine Products Market vs Smoking'''= | ||
=== 2023: [https://pubmed.ncbi.nlm.nih.gov/37540451/ Comparison of smoking prevalence in Canada before and after nicotine vaping product access using the SimSmoke model] === | |||
* Using a version of the ''SimSmoke'' model calibrated to the Canadian population, this study compares actual smoking trends from 2012-2020 with the counterfactual (i.e. what would have been expected in a world without e-cigarettes, as estimated by projecting pre-2012 trends): | |||
** Results: Comparing 2012-2020 survey data of post-NVP to SimSmoke projected smoking prevalence trends, one survey indicated an NVP-related relative reduction of 15% (15%) for males (females) age 15+, but 32% (52%) for those ages 15-24. The other survey indicated a 14% (19%) NVP-related smoking reduction for ages 18+, but 42% (53%) for persons ages 18-24. Much of the gain occurred since Canada relaxed NVP restrictions. NVP-related 2012-2020 smoking reductions yielded 100,000 smoking-attributable deaths averted from 2012 to 2060. | |||
* Levy DT, Cadham CJ, Yuan Z, Li Y, Gravely S, Cummings KM. Can J Public Health. 2023 Aug 4. doi: 10.17269/s41997-023-00792-3. Online ahead of print. PMID: 37540451 | |||
===2022: [https://www.qeios.com/read/GM2450 Higher Sales of Electronic Nicotine Delivery Systems (ENDS) in the US Are Associated with Cigarette Sales Declines, according to a Trend Break Analysis]=== | ===2022: [https://www.qeios.com/read/GM2450 Higher Sales of Electronic Nicotine Delivery Systems (ENDS) in the US Are Associated with Cigarette Sales Declines, according to a Trend Break Analysis]=== | ||
edits